Welcome, Guest. Please login or register.
November 28, 2022, 05:42:27 am

Login with username, password and session length

  • Total Posts: 55082
  • Total Topics: 4843
  • Online Today: 50
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 35
Total: 35


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Hepatitis C Rarely Clears Spontaneously in Those With HIV  (Read 4271 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Hepatitis C Rarely Clears Spontaneously in Those With HIV
« on: April 19, 2018, 10:16:45 am »
People living with HIV who contract hepatitis C virus (HCV) rarely spontaneously clear the latter virus without treatment, Healio reports. Consequently, researchers advocate changing direct-acting antiviral (DAA) labels to specify that they should be prescribed during the acute, or very early, phase of hep C infection among those coinfected with HIV.

Christoph Boesecke, MD, of the University of Bonn in Germany, presented findings from the PROBE-C study at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston.



© 2022 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.